A broader rotation away from tech and a new short-seller report weighed on Palantir, one of the market's biggest winners amid ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Viking Therapeutics stock tumbled after the drugmaker released study results of its experimental weight-loss pill.

Follow all the latest U.S. market action for Tuesday here to see if stocks can shake of some summer torpor and reach fresh ...

The hedge fund founder who kicked off Opendoor's big rally tells Business Insider that the stock could pop another 2,000% by ...

President Trump's tariffs continue to affect global markets and the economy. Follow for live updates on stocks, bonds and other markets, including the Dow Jones Industrial Average, S&P 500 and Nasdaq ...

Opendoor stock may have momentum, but the fundamentals tell a slightly tougher story. At first glance, its Price-to-Sales ...

SoundHound AI stock fell amid a marketwide downturn. Even with solid AI tech and a large backlog, meaningful revenue and ...

Citron Research, the firm led by short-seller Andrew Left, unpacked its bear case for Palantir, using OpenAI to show why it ...

Palantir shares have fallen around 15% across the last five days of trading, completely erasing gains made near the start of ...

Mandell, who previously held shares in Strategy and disclosed a $2.1 million position in Bitwise’s Bitcoin ETF (BITB), ...

Canada's main stock index is set to extend its record-setting run this year and next as lower borrowing costs along with ...